Surgery Partners Total Liabilities 2013-2024 | SGRY
Surgery Partners total liabilities from 2013 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
| Surgery Partners Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $4,694 |
| 2023 | $3,842 |
| 2022 | $3,741 |
| 2021 | $4,148 |
| 2020 | $4,097 |
| 2019 | $3,641 |
| 2018 | $3,218 |
| 2017 | $2,955 |
| 2016 | $1,980 |
| 2015 | $1,807 |
| 2014 | $1,829 |
| 2013 | $489 |
| 2012 | $0 |
| Surgery Partners Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2024-12-31 | $4,694 |
| 2024-09-30 | $4,423 |
| 2024-06-30 | $4,312 |
| 2024-03-31 | $3,938 |
| 2023-12-31 | $3,842 |
| 2023-09-30 | $3,794 |
| 2023-06-30 | $3,638 |
| 2023-03-31 | $3,701 |
| 2022-12-31 | $3,741 |
| 2022-09-30 | $4,431 |
| 2022-06-30 | $4,251 |
| 2022-03-31 | $4,277 |
| 2021-12-31 | $4,148 |
| 2021-09-30 | $4,080 |
| 2021-06-30 | $4,093 |
| 2021-03-31 | $4,094 |
| 2020-12-31 | $4,097 |
| 2020-09-30 | $4,088 |
| 2020-06-30 | $3,935 |
| 2020-03-31 | $3,763 |
| 2019-12-31 | $3,641 |
| 2019-09-30 | $3,525 |
| 2019-06-30 | $3,469 |
| 2019-03-31 | $3,429 |
| 2018-12-31 | $3,218 |
| 2018-09-30 | $2,979 |
| 2018-06-30 | $2,987 |
| 2018-03-31 | $2,955 |
| 2017-12-31 | $2,955 |
| 2017-09-30 | $2,896 |
| 2017-06-30 | $2,356 |
| 2017-03-31 | $1,970 |
| 2016-12-31 | $1,980 |
| 2016-09-30 | $1,931 |
| 2016-06-30 | $1,900 |
| 2016-03-31 | $1,910 |
| 2015-12-31 | $1,807 |
| 2015-09-30 | $1,874 |
| 2015-06-30 | $0 |
| 2015-03-31 | $0 |
| 2014-12-31 | |
| 2014-09-30 | $0 |
| 2013-12-31 | $489 |
| 2012-12-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $2.841B | $3.114B |
| Surgery Partners, Inc. is a healthcare services company. The Company's outpatient delivery model focused on providing solutions for surgical and related ancillary care in support of its patients and physicians. Its operating segment consists of Surgical Facility Services segment, Ancillary Services segment and Optical Services segment. Surgery Partners, Inc. is based in Nashville, Tennessee. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $135.784B | 25.47 |
| Elevance Health (ELV) | United States | $91.409B | 11.80 |
| CVS Health (CVS) | United States | $84.718B | 10.53 |
| Cencora (COR) | United States | $54.879B | 19.08 |
| DiDi Global (DIDIY) | China | $20.661B | 31.36 |
| Natera (NTRA) | United States | $20.542B | 0.00 |
| BioMerieux (BMXMF) | France | $15.263B | 0.00 |
| Solventum (SOLV) | United States | $12.150B | 12.86 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.973B | 0.00 |
| Doximity (DOCS) | United States | $11.050B | 57.47 |
| CochLear (CHEOY) | Australia | $10.944B | 0.00 |
| ICON (ICLR) | Ireland | $10.818B | 10.06 |
| Revvity (RVTY) | United States | $10.756B | 18.51 |
| Viatris (VTRS) | United States | $10.293B | 3.54 |
| Medpace Holdings (MEDP) | United States | $8.508B | 22.60 |
| Sonic Healthcare (SKHHY) | Australia | $8.280B | 0.00 |
| Avantor (AVTR) | United States | $8.191B | 11.90 |
| HealthEquity (HQY) | United States | $7.819B | 38.47 |
| Charles River Laboratories (CRL) | United States | $6.817B | 13.36 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| Bausch + Lomb (BLCO) | Canada | $3.982B | 23.48 |
| BrightSpring Health Services (BTSG) | United States | $3.976B | 36.81 |
| Sotera Health (SHC) | United States | $3.727B | 21.18 |
| Alignment Healthcare (ALHC) | United States | $2.991B | 0.00 |
| Concentras Parent (CON) | United States | $2.743B | 15.85 |
| Organon (OGN) | United States | $2.264B | 2.41 |
| Premier (PINC) | United States | $2.106B | 14.42 |
| Ardent Health Partners (ARDT) | United States | $2.077B | 8.85 |
| Progyny (PGNY) | United States | $1.815B | 39.98 |
| GeneDx Holdings (WGS) | United States | $1.687B | 64.99 |
| GoodRx Holdings (GDRX) | United States | $1.657B | 30.86 |
| PACS (PACS) | United States | $1.590B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.248B | 9.50 |
| Teladoc Health (TDOC) | United States | $1.247B | 0.00 |
| Agilon Health (AGL) | United States | $1.196B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.039B | 0.00 |
| Establishment Labs Holdings (ESTA) | $0.978B | 0.00 | |
| CareDx (CDNA) | United States | $0.855B | 13.36 |
| AMN Healthcare Services Inc (AMN) | United States | $0.840B | 7.89 |
| Embecta (EMBC) | United States | $0.696B | 4.71 |
| QDM (QDMI) | Hong Kong, SAR China | $0.690B | 0.00 |
| Nutex Health (NUTX) | United States | $0.667B | 13.08 |
| Enhabit (EHAB) | United States | $0.521B | 42.83 |
| Auna S.A (AUNA) | Luxembourg | $0.508B | 13.45 |
| InnovAge Holding (INNV) | United States | $0.491B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.466B | 0.00 |
| LifeMD (LFMD) | United States | $0.375B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.352B | 0.00 |
| SBC Medicals (SBC) | United States | $0.345B | 0.00 |
| Beauty Health (SKIN) | United States | $0.234B | 0.00 |
| Oncology Institute (TOI) | United States | $0.212B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.195B | 0.00 |
| DocGo (DCGO) | United States | $0.143B | 23.33 |
| Basel Medical Group (BMGL) | Singapore | $0.088B | 0.00 |
| So-Young (SY) | China | $0.086B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.084B | 0.00 |
| OncoCyte (OCX) | United States | $0.082B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.076B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Biodesix (BDSX) | United States | $0.054B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.029B | 0.00 |
| KindlyMD (KDLY) | United States | $0.023B | 0.00 |
| ModivCare (MODV) | United States | $0.017B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.011B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |